Varian to purchase GE's radiotherapy unit

Article

Varian Associates has offered to purchase the radiotherapy service and support operation of GE Medical Systems in a deal that will cover all of the Milwaukee vendor's worldwide radiotherapy service and customer support operations. GEMS has a global

Varian Associates has offered to purchase the radiotherapy service and support operation of GE Medical Systems in a deal that will cover all of the Milwaukee vendor's worldwide radiotherapy service and customer support operations. GEMS has a global installed base of 400 linear accelerator systems and some 340 treatment planning products, according to the companies. The sale does not include GE's radiotherapy manufacturing and engineering unit located in Buc, France, which is under review, according to GEMS.

The purchase, for an undisclosed amount of cash, is expected to be completed by the end of 1997. About 160 GEMS radiotherapy service professionals, technical support personnel, and support staff will join Varian on completion of the transaction. Varian executives said that the acquisition significantly broadens the Palo Alto, CA-based company's international radiotherapy support. For GEMS, the deal allows the vendor to focus more closely on its core medical imaging, services, and information technology businesses, according to Jeffrey Immelt, president and CEO.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.